1.Diagnosis and Treatment Strategy of Pulmonary Embolism after Video-assisted Thoracic Lobectomy.
Hao XU ; Congying GUO ; Yu LU ; Linyou ZHANG
Chinese Journal of Lung Cancer 2018;21(10):790-792
BACKGROUND:
To summarize the clinical features of patients with pulmonary embolism after lobectomy and to explore the methods of diagnosis and treatment of pulmonary embolism after lobectomy.
METHODS:
The clinical data of 6 patients with pulmonary embolism after lobectomy between July 2007 and July 2017 were retrospectively analyzed.
RESULTS:
Of the 6 patients, 3 died within 24 h of onset and 3 patients were cured and discharged.
CONCLUSIONS
Pulmonary embolism after lobectomy is a rare postoperative complication in thoracic surgery. It is difficult to diagnose and has a high mortality rate. Preoperative thromboembolic risk assessment and postoperative prevention are important.
Aged
;
Female
;
Humans
;
Lung Neoplasms
;
surgery
;
Male
;
Middle Aged
;
Pneumonectomy
;
adverse effects
;
Postoperative Complications
;
diagnosis
;
etiology
;
therapy
;
Pulmonary Embolism
;
diagnosis
;
etiology
;
therapy
;
Retrospective Studies
;
Thoracic Surgery, Video-Assisted
;
adverse effects
2.Diagnosis and Management of Postoperative Acute Pulmonary Embolism after Thoracic Surgeries - Experience of Diagnosis and Management for 37 Patients with Postoperative Acute Pulmonary Embolism after Thoracic Surgeries.
Zhe XU ; Xiaoxi FAN ; Shun XU
Chinese Journal of Lung Cancer 2018;21(10):773-778
BACKGROUND:
Pulmonary embolism (PE) is one of the most severe complications after thoracic surgeries. Thus it is of great importance to learn the characteristics of acute PE after thoracic surgeries. This study summarized the clinical characteristics and experience on the diagnosis and treatment of 37 patients with postoperative acute pulmonary embolism, in order to improve its prophylaxis and management level.
METHODS:
We retrospectively reviewed 37 patients with postoperative acute pulmonary embolism following thoracic surgeries. Age, gender, body mass index (BMI), diagnosis, surgical procedure, onset time, clinical presentation, diagnosis and management were comprehensively analyzed.
RESULTS:
There were 16 males (43.2%) and 21 females (56.8%). The average age was (65.64±6.29) years (range from 53 years to 82 years) and 32 patients were over 60 years. BMI ranged from 17.1 kg/m² to 30.8 kg/m² with median of 26.3 kg/m². And 27 patients' BMI (73.0%) were over 25.0 kg/m². Thirty-four patients (91.9%) were with malignancies. Median presentation time was the 4th day postoperatively, while 11 patients were presented on the 3rd day postoperatively which accounted for the most. Patients with acute pulmonary embolism accounted for 77.8% from 9 am to 9 pm. D-dimer (D-D) ranged from 1.0 μg/mL-20.0 μg/mL (FEU) with median of (7.09±4.45) μg/mL (FEU) and 32 (86.5%) patients' D-D were over 3.00 μg/mL (FEU).
CONCLUSIONS
The survival rate of postoperative acute pulmonary embolism can be increased by fully understanding its clinical characteristics, early diagnosis and multiple disciplinary treatment.
Acute Disease
;
Aged
;
Aged, 80 and over
;
Female
;
Humans
;
Lung Neoplasms
;
surgery
;
Male
;
Middle Aged
;
Postoperative Complications
;
diagnosis
;
etiology
;
therapy
;
Pulmonary Embolism
;
diagnosis
;
etiology
;
therapy
;
Retrospective Studies
;
Survival Rate
;
Thoracic Surgical Procedures
;
adverse effects
3.Achalasia secondary to lung adenocarcinoma.
Burak CAN ; Fatih BALLI ; Ugur KORKMAZ ; Hasan YILMAZ ; Fatma Inci CAN ; Altay CELEBI
The Korean Journal of Internal Medicine 2015;30(2):250-251
No abstract available.
Adenocarcinoma/*complications/diagnosis
;
Aged
;
Esophageal Achalasia/diagnosis/*etiology/physiopathology
;
Esophageal Sphincter, Upper/physiopathology
;
Humans
;
Lung Neoplasms/*complications/diagnosis
;
Male
;
Neoplasm Staging
;
Predictive Value of Tests
;
Risk Factors
;
Tomography, X-Ray Computed
5.Therapy-Related Acute Megakaryoblastic Leukemia in a Lung Cancer Patient.
Jung Joo MOON ; Myung Hyun NAM ; Chae Seung LIM ; Chang Kyu LEE ; Yunjung CHO ; Soo Young YOON
Annals of Laboratory Medicine 2014;34(2):155-158
No abstract available.
Aged
;
Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use
;
Blood Cells/pathology
;
Bone Marrow Cells/pathology
;
Carcinoma, Non-Small-Cell Lung/*drug therapy/radiotherapy
;
Humans
;
Karyotyping
;
Leukemia, Megakaryoblastic, Acute/*diagnosis/etiology
;
Lung Neoplasms/*drug therapy/radiotherapy
;
Male
6.A Case of Pneumatosis Intestinalis Associated with Sunitinib Treatment for Renal Cell Carcinoma.
Yoo A CHOI ; Eun Hui SIM ; Kyoung Eun LEE ; Sun Young KO ; Min Ji SEO ; Young Jun YANG ; Ji Chan PARK ; Suk Young PARK
The Korean Journal of Gastroenterology 2013;61(6):347-350
Sunitinib as a multitarget tyrosine kinase inhibitor is one of the anti-tumor agents, approved by the United States Food and Drug Administration to use treat gastrointestinal stromal tumor and metastatic renal cell carcinoma. The agent is known to commonly induce adverse reactions such as fatigue, nausea, diarrhea, stomatitis, esophagitis, hypertension, skin toxicity, reduciton in cardiac output of left ventricle, and hypothyroidism. However, it has been reported to rarely induce adverse reactions such as nephrotic syndrome and irreversible reduction in renal functions, and cases of intestinal perforation or pneumatosis interstinalis as such reactions have been consistently reported. In this report, a 66-year old man showing abdominal pain had renal cell carcinoma and history of sunitinib at a dosage of 50 mg/day on a 4-weeks-on, 2-weeks-off schedule. Seven days after the third cycle he was referred to the hospital because of abdominal pain. Computed tomography showed pneumoperitoneum with linear pneumatosis intestinalis in his small bowel. The patient underwent surgical exploration that confirmed the pneumatosis intestinalis at 100 cm distal to Treitz's ligament. We report a rare case of intestinal perforation with pneumatosis intestinalis after administration of sunitinib to a patient with metastatic renal cell carcinoma.
Aged
;
Antineoplastic Agents/adverse effects/*therapeutic use
;
Carcinoma, Renal Cell/*drug therapy
;
Drug Administration Schedule
;
Humans
;
Indoles/adverse effects/*therapeutic use
;
Intestinal Perforation/*diagnosis/etiology/surgery
;
Kidney Neoplasms/*drug therapy
;
Lung/radiography
;
Male
;
Pneumatosis Cystoides Intestinalis/*diagnosis/etiology
;
Positron-Emission Tomography
;
Pyrroles/adverse effects/*therapeutic use
;
Tomography, X-Ray Computed
7.Metastatic Common Bile Duct Cancer from Pulmonary Adenocarcinoma Presenting as Obstructive Jaundice.
In Hye CHA ; Jin Nam KIM ; You Sun KIM ; Soo Hyung RYU ; Jeong Seop MOON ; Hye Kyung LEE
The Korean Journal of Gastroenterology 2013;61(1):50-53
We report an extremely rare case of metastatic common bile duct cancer from pulmonary adenocarcinoma presenting as obstructive jaundice. The patient was a 76-year-old male, who presented with generalized weakness and right upper quadrant pain. Plain chest X-ray noted multiple small nodules in both lung fields. Abdominal computed tomography scan showed a stricture of the mid common bile duct along with ductal wall enhancement. Endoscopic retrograde cholangiography revealed a concentric, abrupt narrowing of the mid-common bile duct suggestive of primary bile duct cancer. However, pathology comfirmed metastatic common bile duct cancer arising from pulmonary adenocarcinoma with immunohistochemical study with thyroid transcriptional factor-1 (TTF-1).
Adenocarcinoma/*diagnosis/pathology/radiography
;
Aged
;
Brain Neoplasms/radiography/secondary
;
Bronchoscopy
;
Cholangiopancreatography, Endoscopic Retrograde
;
Common Bile Duct Neoplasms/*diagnosis/secondary
;
DNA-Binding Proteins/metabolism
;
Humans
;
Immunohistochemistry
;
Jaundice, Obstructive/*etiology
;
Lung Neoplasms/*diagnosis/pathology/radiography
;
Male
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
8.Pulmonary Tuberculosis and Lung Cancer Risk in Current Smokers: The Seoul Male Cancer Cohort Study.
Jong Myon BAE ; Zhong Min LI ; Myung Hee SHIN ; Dong Hyun KIM ; Moo Song LEE ; Yoon Ok AHN
Journal of Korean Medical Science 2013;28(6):896-900
Authors evaluated pulmonary tuberculosis (PTB) history as a risk factor for lung cancer in current male smokers in a prospective, population-based cohort study. The subjects were the 7,009 males among the participants in the Seoul Male Cancer Cohort Study for whom there was full information on PTB history and smoking habits. With a 16-yr follow-up, 93 cases of lung cancer occurred over the 99,965 person-years of the study. The estimated relative risk (RR) of PTB history of current smokers in lung cancer after adjusting for three confounders - intake of coffee and tomatoes, and age at entry - was 1.85 (95% CI: 1.08-3.19). The observed joint RRs and attributable risks (ARs) across strata of three confounders were greater than the expected, indicating a positive interaction. Thus a history of PTB in current smokers may be another risk factor for lung cancer. Based on a synergic interaction, a heavy male smoker with a PTB history would be expected to belong to the group at high risk of lung cancer.
Adult
;
Cohort Studies
;
Follow-Up Studies
;
Humans
;
Lung Neoplasms/*diagnosis/etiology
;
Male
;
Middle Aged
;
Prospective Studies
;
Republic of Korea
;
Risk Factors
;
*Smoking
;
Time Factors
;
Tuberculosis, Pulmonary/complications/*diagnosis
9.Comprehensive analysis of asbestos-induced occupational lung cancer and mesothelioma.
Li HUANG ; Jun-ming DAI ; Hua FU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2013;31(1):19-23
OBJECTIVETo revise diagnosis criteria of asbestos-induced occupational lung cancer.
METHODSAll literatures which met the criteria of cohort studies with results of lung cancer incidence or mortality among workers exposed to asbestos would incorporate into the systematic review. Meanwhile, the information about diagnosis criteria on asbestos-induced lung cancer in other countries was collected. Meta analysis was used to calculate meta-SMR and its 95% confidence interval.
RESULTS21 asbestos-exposed cohorts were summarized. The percentage of all deaths due to mesothelioma was 0 to 36.36%. The main kind of asbestos-exposed raw material was chrysotile which accounted for 47.6%, and 7 cohorts (33.3%) didn't provide the information. There were 13 cohorts in 15 which concluded that the lung cancer risk of workers with asbestos exposure had increased (lung cancer SMR = 1.6 ∼ 6.52, P < 0.05). Meta-SMR of 10 included cohorts is 2.09, with 95%CI 1.73 to 2.52 by using Meta analysis. When cumulative asbestos exposure years were less than one year, the risk of lung cancer had increased (lung cancer SMR = 1.6 ∼ 1.82, P < 0.05). When latent period of lung cancer was more than 15 years, the risk of lung cancer had increased (lung cancer SMR = 2.08 ∼ 3.75, P < 0.05). There were three studies, which had analyzed the relation between cumulative asbestos exposure years and the risk of mesothelioma, showing that when cumulative asbestos exposure years were less than one year, the risk of mesothelioma had increased (mesothelioma SMR = 18.0 ∼ 20.0, P < 0.05). When latent period of mesothelioma was more than 15 years, the risk of mesothelioma had increased.
CONCLUSIONThe emphasis of the new version of asbestos-induced lung cancer and mesothelioma diagnosis criteria should focus on cumulative asbestos exposure years and latent period.
Asbestos ; adverse effects ; Humans ; Lung Neoplasms ; diagnosis ; etiology ; Mesothelioma ; diagnosis ; etiology ; Occupational Diseases ; diagnosis ; Occupational Exposure ; Risk Assessment
10.Feasibility of galactomannan assay in bronchoalveolar lavage fluid in diagnosis of hematologic malignancy patients with invasive fungal infections.
Yun LENG ; Wen-Ming CHEN ; Jin-Wei LIU
Chinese Journal of Hematology 2011;32(8):551-552
Adolescent
;
Adult
;
Aged
;
Bronchoalveolar Lavage Fluid
;
Feasibility Studies
;
Female
;
Hematologic Neoplasms
;
microbiology
;
Humans
;
Lung Diseases, Fungal
;
diagnosis
;
etiology
;
Male
;
Mannans
;
analysis
;
Middle Aged
;
Young Adult

Result Analysis
Print
Save
E-mail